InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by 이희용, 董事长兼首席执行官. Director active across 2 companies, notably 지투지바이오. Cumulatively, 16 disclosures have been recorded. Activity tracked since 25 March 2026. The latest transaction was filed on 25 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 条申报中的 16 条
이희용 is Président-Directeur Général and is reported as a 대량보유자 at 지투지바이오, on XKRX. The record shows 8 filings in total, and across the sampled recent filings from 2025-09-08 to 2026-06-05, purchases total EUR 53038 and sales total EUR 0.